Comparison candidate Tick-borne encephalitis virus vaccines based on mRNA, adenovirus serotype 25 and chimera of YFV vaccine strain
Kuznetsova, N. A.; Gushchin, V. A.; Marchuk, E. V.; Siniavin, A.; Kleymenov, D. A.; Nikiforova, M.; Zubkova, O. V.; Vavilova, I. V.; Ozharovskaia, T. A.; Mazunina, E. P.; Bykonia, E. N.; Bogdanov, E. Y.; Zolotar, A. N.; Shidlovskaya, E. V.; Usachev, E. V.; Usacheva, O. V.; Shatalov, A. G.; Zlobin, V. I.; Logunov, D. Y.; Gintsburg, A. L.
Show abstract
BackgroundDespite the availability of several licensed inactivated vaccines, the development of new vaccines against the Tick-borne encephalitis virus (TBEV) remains an important task, especially in countries endemic to this pathogen. The risk of infection with TBEV increases every year because of increase in the number of ticks, the emergence of tick carriers into new territories, and active human activity in areas of TBEV natural foci. Annual reports of vaccination failures have prompted us to search for approaches to creating a new vaccine. ObjectivesIn our study, we used the same PrM and E antigens to produce three vaccine candidates against tick-borne encephalitis (TBE): 1) a live attenuated YFV 17DD-UN vaccine strain, 2) recombinant adenovirus (rAd) vectors, and 3) mRNA encapsulated in lipid nanoparticles (LNP). MethodsWe generated and assessed the immunogenicity and protective efficacy of three candidate TBEV vaccines based on mRNA, simian adenovirus type 25, and a chimera of the YFV 17DD-UN attenuated strain. ResultsAnalysis of the virus-neutralizing titers in the blood sera of immunized mice revealed a statistically significant difference among the three candidate vaccines. The immunogenicity and protective efficacy of the candidate mRNA-LNP vaccine were found to be higher than those of the other two vaccines. ConclusionsBased on the results of our study, it can be concluded that the mRNA-based platform is more promising for the creation of a vaccine against TBEV.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The chicken chorioallantoic membrane model for isolation of CRISPR/cas9-based HSV-1 mutant expressing tumor suppressor p53 97%
- Difference in TMPRSS2 usage by Delta and Omicron variants of SARS-CoV-2: Implication for a sudden increase among children 95%
- Epidemiological survey of serum titers from adults against various Gram-negative bacterial V-antigens 95%
Similar papers in this journal
- IgY antibodies against Ebola virus possess post-exposure protection and excellent thermostability 96%
- Genetic diversity and evolution of Hantaan virus in China and its neighbors 94%
- The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation 94%
Similar papers in this journal
- A new Dicistrovirus from soldier fly Inopus flavus (James) (Diptera: Stratiomyidae), a pest of sugarcane. 94%
- Molecular characterization of a novel cytorhabdovirus with a unique genomic organization infecting yerba mate (Ilex paraguariensis) in Argentina 93%
- Exploring the tymovirids landscape through metatranscriptomics data 93%
Similar papers in this journal
- Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice 92%
- Multiplexed VaxArray Immunoassay for Rapid Antigen Quantification in Measles and Rubella Vaccine Manufacturing 91%
- Safety and Immunogenicity of CoronaVac and ChAdOx1 Against the SARS-CoV-2 Circulating Variants of Concern (Alpha, Delta, Beta) in Thai Healthcare Workers 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.